Sort
21,281 grants matching “influenza”
Successful Clinical Response In Pneumonia Therapy (SCRIPT) Systems Biology Center
$2,280,000Richard G Wunderink · Northwestern University At Chicago · U19 · FY2021 · AI
Computer Simulations of Membranes and Biopolymers
$2,279,017Richard Walter Pastor · National Heart, Lung, And Blood Institute · ZIA · FY2023 · HL
Influenza responses and repertoire in vaccination, infection and tonsil organoids.
$2,277,543Mark M Davis · Stanford University · U19 · FY2021 · AI
Structure-function analysis of infection- and vaccine-induced B-cell repertoires
$2,268,881Stephen C Harrison · Boston Children'S Hospital · P01 · FY2014 · AI
(HVTN) HIV VACCINE TRIAL UNITS
$2,267,098Johns Hopkins University · U01 · FY2000 · AI
Biodefense/Emerging Infection Vaccine Studies
$2,265,989Julie E. Ledgerwood · National Institute Of Allergy And Infectious Diseases · ZIA · FY2016 · AI
Viral Immunity and VAccination (VIVA) Human Immunology Project Consortium (HIPC)
$2,265,730Ana Fernandez-Sesma · Icahn School Of Medicine At Mount Sinai · U19 · FY2023 · AI
Viral Immunity and VAccination (VIVA) Human Immunology Project Consortium (HIPC)
$2,265,730Ana Fernandez-Sesma · Icahn School Of Medicine At Mount Sinai · U19 · FY2022 · AI
Viral Immunity and VAccination (VIVA) Human Immunology Project Consortium (HIPC)
$2,265,730Ana Fernandez-Sesma · Icahn School Of Medicine At Mount Sinai · U19 · FY2024 · AI
Viral Immunity and VAccination (VIVA) Human Immunology Project Consortium (HIPC)
$2,265,730Ana Fernandez-Sesma · Icahn School Of Medicine At Mount Sinai · U19 · FY2025 · AI
Maternal and infant immunization to eliminate breast milk transmission of HIV-1
$2,263,268Sallie R. Permar · Duke University · P01 · FY2017 · AI
Innovative Approaches to the Study of Social Determinants of Health in Children
$2,262,368Katherine Babcock Ehrlich · University Of Georgia · DP2 · FY2018 · MD
Oklahoma Center of Biomedical Research Excellence (COBRE) in Structural Biology
$2,262,175Ann H West · University Of Oklahoma · P20 · FY2012 · GM
Direct and Indirect Protection by Influenza Vaccine Given to Children in India
$2,258,000Wayne M Sullender · University Of Alabama At Birmingham · U01 · FY2010 · IP
CEIRS Influenza Data Processing and Coordinating Center (DPCC)
$2,256,044Gillian Air · Digital Infuzion, Inc. · N01 · FY2017 · AI
IP21-002, New Vaccine Surveillance Network
$2,254,027Marian G Michaels · University Of Pittsburgh At Pittsburgh · U01 · FY2025 · IP
Leadership Group for the Infectious Diseases Clinical Research Consortium (IDCRCLG) - Momi-Vax DMID #21-0004 {Supplement #6}
$2,253,969David S Stephens · Emory University · UM1 · FY2021 · AI
Phylodynamics of Cell Populations
$2,252,479Kenneth Hoehn · Dartmouth College · R35 · FY2025 · GM
Center for Lung Biology and Disease
$2,251,189Samithamby Jeyaseelan · Louisiana State Univ A&M Col Baton Rouge · P20 · FY2020 · GM
Center for Statistics and Quantitative Infectious Diseases
$2,250,371M Elizabeth Halloran · Fred Hutchinson Cancer Research Center · U54 · FY2015 · GM
Kaiser Washington Vaccine and Treatment Evaluation Unit
$2,248,353Lisa A Jackson · Kaiser Foundation Research Institute · UM1 · FY2022 · AI
Center for Lung Biology and Disease
$2,246,019Samithamby Jeyaseelan · Louisiana State Univ A&M Col Baton Rouge · P20 · FY2021 · GM
Influenza responses and repertoire in vaccination, infection and tonsil organoids.
$2,244,245Mark M Davis · Stanford University · U19 · FY2022 · AI
Safety/Tolerability/Immunogenicity of first-in-human Aβ DNA vaccine, AV-1959D Phase 1 trials in early-stage AD subjects: based on IND18953 cleared by FDA.
$2,243,861Michael G Agadjanyan · Institute For Molecular Medicine · R01 · FY2024 · AG
Development of vaccines to bacterial diseases found especially in children
$2,243,180John Robbins · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2012 · HD